Which EU countries could reverse their nuclear energy phaseouts?

EU nuclear generation ticked up 4.8% between 2023 and 2024 (driven by France's +12.5%) amid renewed debate about reversing phaseouts as a route to energy security. The European Commission for the first time proposed making nuclear eligible for 2028–2034 EU funding (a proposal seen as unlikely to pass), while countries including Belgium, Italy and the Netherlands are exploring life extensions, restarts or new builds and 11 member states signed a declaration to “fully unlock” nuclear potential. Alternatives such as small modular reactors (SMRs) are being considered to lower upfront costs, but plans face political, cost and waste-management opposition, and renewables still supply under half of EU electricity — keeping supply risks and policy uncertainty high for utilities and infrastructure investors.

Analysis

Market structure: A modest policy tilt toward nuclear benefits incumbent nuclear utilities (EDF.PA), nuclear fuel producers (Cameco/CCJ) and engineering vendors (Rolls-Royce/RR.L, BWXT.BWXT) via higher long‑cycle capex and fuel demand; pure‑play renewables developers (e.g., Ørsted/ORSTED.CO) risk relative de‑rating if policy subsidies and grid priority shift. Pricing power will shift slowly — life‑extensions and SMRs compress time‑to‑market vs. gigawatt builds, raising near‑term demand for uranium and services by mid‑single digit % annually if 5–10 EU states extend reactors.

Risk assessment: Tail risks include political reversals (national referenda or EU court rulings) and catastrophic project cost overruns that could write down vendor equities by >50%; operational risks (waste storage bottlenecks) could create multi‑year delays. Immediate market moves will be event‑driven (weeks around votes); meaningful cashflows for builders occur over 3–10 years, so horizon matters for sizing.

Trade implications: Favor upstream commodities and SMR/vender exposure on a 6–24 month view: uranium producers should outperform if restart/life‑extension scenarios materialize; buy 12–24m call spreads to cap cost. Rotate from pure renewable growth names into diversified utilities and grid/integration stocks that monetize baseload (transformers, storage, interconnectors) over next 12–36 months.

Contrarian angles: Consensus underestimates financing bottlenecks and industrial base rebuild time — market may underprice modular SMR vendors while overpricing near‑term benefits to incumbents. Historical parallel: 2000s nuclear restarts show policy talk precedes 5–10 year lag to material builds; that gap creates opportunities in suppliers and fuel, not necessarily in large reactor contractors whose margins erode through overruns.

Key Decisions for Investors

• Establish a 2–3% portfolio long in Cameco (CCJ) over 12–24 months to capture higher uranium demand from life‑extensions/SMRs; use a 15% stop and take profits at +35–50% or if spot uranium rises >30% from current levels.
• Long EDF.PA 2% and short ENGIE.PA 1.5% as a pair trade (6–18 month horizon): long exposure to incumbent nuclear operator vs. short exposure to a renewables‑tilted competitor if EU/national signals favor life‑extensions; rebalance after major votes or if differential moves >20%.
• Buy 12–18 month call spreads on Rolls‑Royce (RR.L) sized 0.5–1% of portfolio (buy 1–2 strikes 10–30% OTM depending on premium) to express SMR manufacturing upside while capping premium; close on proof‑of‑concept delays beyond 24 months.
• Reduce pure‑play offshore/wind positions (e.g., ORSTED.CO) by 30–50% within 3 months and redeploy into grid/integrator names (transformers, battery integrators) to hedge increased baseload and storage demand over 1–3 years.
• Event trigger: if EU budget vote to allow nuclear funding is scheduled within 3–6 months, increase uranium/SMR exposure by 50% pre‑vote and tighten stops; if the vote fails, reduce exposure by 40% within 2 weeks.